1. Home
  2. GOSS
  3. GOSS News

Latest Gossamer Bio Inc. (GOSS) News on September 7, 2025

H.C. Wainwright and Leerink Partners Reiterate ‘Buy’ Ratings on Gossamer Bio, Inc. (GOSS)
GOSS

Insider Monkey

20 days ago

H.C. Wainwright and Leerink Partners Reiterate ‘Buy’ Ratings on Gossamer Bio, Inc. (GOSS)

Gossamer Bio Completes Enrollment for Phase 3 PROSERA Study of PAH Drug Seralutinib
GOSS

Insider Monkey

2 months ago

Gossamer Bio Completes Enrollment for Phase 3 PROSERA Study of PAH Drug Seralutinib

Gossamer Bio Announces Completion of Enrollment in Registrational Phase 3 PROSERA Study for the Treatment of PAH
GOSS

Business Wire

3 months ago

Gossamer Bio Announces Completion of Enrollment in Registrational Phase 3 PROSERA Study for the Treatment of PAH

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GOSS

Business Wire

3 months ago

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Presenting on Emerging Growth Conference 82 Day 2 on May 22; Register to live stream
GOSS

GlobeNewswire

4 months ago

Presenting on Emerging Growth Conference 82 Day 2 on May 22; Register to live stream

GOSS

Thomson Reuters StreetEvents

4 months ago

Q1 2025 Gossamer Bio Inc Earnings Call

Gossamer Bio Inc (GOSS) Q1 2025 Earnings Call Highlights: Strategic Progress Amid Financial ...
GOSS

GuruFocus.com

4 months ago

Gossamer Bio Inc (GOSS) Q1 2025 Earnings Call Highlights: Strategic Progress Amid Financial ...

Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates
GOSS

Zacks

4 months ago

Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates

GOSS

Associated Press Finance

4 months ago

Gossamer Bio: Q1 Earnings Snapshot

Gossamer Bio Announces First Quarter 2025 Financial Results and Provides Business Update, Including Closure of New Patient Screening in Phase 3 PROSERA Study
GOSS

Business Wire

4 months ago

Gossamer Bio Announces First Quarter 2025 Financial Results and Provides Business Update, Including Closure of New Patient Screening in Phase 3 PROSERA Study

What To Expect From Gossamer Bio Inc (GOSS) Q1 2025 Earnings
GOSS

GuruFocus.com

4 months ago

What To Expect From Gossamer Bio Inc (GOSS) Q1 2025 Earnings

Gossamer Bio to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15, 2025
GOSS

Business Wire

4 months ago

Gossamer Bio to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15, 2025

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GOSS

Business Wire

4 months ago

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Gossamer Bio to Present Preclinical Data at the American Thoracic Society (ATS) 2025 International Conference
GOSS

Business Wire

4 months ago

Gossamer Bio to Present Preclinical Data at the American Thoracic Society (ATS) 2025 International Conference

3 Promising Penny Stocks With Market Caps Over $100M
GOSS

Simply Wall St.

4 months ago

3 Promising Penny Stocks With Market Caps Over $100M

Pleasing Signs As A Number Of Insiders Buy Gossamer Bio Stock
GOSS

Simply Wall St.

5 months ago

Pleasing Signs As A Number Of Insiders Buy Gossamer Bio Stock

Is Gossamer Bio Inc. (NASDAQ:GOSS) the Best Penny Stock to Invest in Under $1?
GOSS

Insider Monkey

5 months ago

Is Gossamer Bio Inc. (NASDAQ:GOSS) the Best Penny Stock to Invest in Under $1?

Gossamer Bio, Inc. (GOSS): Among Stocks Under $10 that Will Triple
GOSS

Insider Monkey

5 months ago

Gossamer Bio, Inc. (GOSS): Among Stocks Under $10 that Will Triple

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GOSS

Business Wire

5 months ago

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Is Gossamer Bio Inc. (GOSS) the Popular Penny Stock on Robinhood to Watch?
GOSS

Insider Monkey

5 months ago

Is Gossamer Bio Inc. (GOSS) the Popular Penny Stock on Robinhood to Watch?

Is Gossamer Bio, Inc. (GOSS) The Hot Biotech Stock Under $5?
GOSS

Insider Monkey

5 months ago

Is Gossamer Bio, Inc. (GOSS) The Hot Biotech Stock Under $5?

Gossamer Bio (GOSS): Among the Penny Stocks With Huge Upside Potential According to Analysts
GOSS

Insider Monkey

5 months ago

Gossamer Bio (GOSS): Among the Penny Stocks With Huge Upside Potential According to Analysts

Gossamer Bio (GOSS) Reports Q4 Loss, Tops Revenue Estimates
GOSS

Zacks

6 months ago

Gossamer Bio (GOSS) Reports Q4 Loss, Tops Revenue Estimates

GOSS

Associated Press Finance

6 months ago

Gossamer Bio: Q4 Earnings Snapshot

Gossamer Bio Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
GOSS

Business Wire

6 months ago

Gossamer Bio Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

3 Promising Penny Stocks With Over $100M Market Cap
GOSS

Simply Wall St.

6 months ago

3 Promising Penny Stocks With Over $100M Market Cap

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GOSS

Business Wire

6 months ago

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

With 60% ownership of the shares, Gossamer Bio, Inc. (NASDAQ:GOSS) is heavily dominated by institutional owners
GOSS

Simply Wall St.

6 months ago

With 60% ownership of the shares, Gossamer Bio, Inc. (NASDAQ:GOSS) is heavily dominated by institutional owners

Presenting on the Emerging Growth Conference 79 Day 2 on February 19 Register Now
GOSS

GlobeNewswire

7 months ago

Presenting on the Emerging Growth Conference 79 Day 2 on February 19 Register Now

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GOSS

Business Wire

7 months ago

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Gossamer Bio Presented Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress
GOSS

Business Wire

7 months ago

Gossamer Bio Presented Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress

Gossamer Bio And 2 Other Promising Penny Stocks On US Exchanges
GOSS

Simply Wall St.

7 months ago

Gossamer Bio And 2 Other Promising Penny Stocks On US Exchanges

Gossamer Bio to Present Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress
GOSS

Business Wire

7 months ago

Gossamer Bio to Present Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GOSS

Business Wire

8 months ago

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Why Gossamer Bio, Inc. (GOSS) Is Among the Best Penny Stocks to Invest In According to Media?
GOSS

Insider Monkey

8 months ago

Why Gossamer Bio, Inc. (GOSS) Is Among the Best Penny Stocks to Invest In According to Media?

3 US Penny Stocks With Market Caps Over $100M
GOSS

Simply Wall St.

8 months ago

3 US Penny Stocks With Market Caps Over $100M

Gossamer Bio (GOSS) Upgraded to Buy: Here's What You Should Know
GOSS

Zacks

8 months ago

Gossamer Bio (GOSS) Upgraded to Buy: Here's What You Should Know

US Penny Stocks: 3 Picks With Market Caps Under $200M
GOSS

Simply Wall St.

9 months ago

US Penny Stocks: 3 Picks With Market Caps Under $200M

All You Need to Know About Gossamer Bio (GOSS) Rating Upgrade to Buy
GOSS

Zacks

10 months ago

All You Need to Know About Gossamer Bio (GOSS) Rating Upgrade to Buy

After Plunging -20% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS)
GOSS

Zacks

10 months ago

After Plunging -20% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS)

After Plunging -15.92% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS)
GOSS

Zacks

10 months ago

After Plunging -15.92% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS)

Industry Analysts Just Made A Sizeable Upgrade To Their Gossamer Bio, Inc. (NASDAQ:GOSS) Revenue Forecasts
GOSS

Simply Wall St.

10 months ago

Industry Analysts Just Made A Sizeable Upgrade To Their Gossamer Bio, Inc. (NASDAQ:GOSS) Revenue Forecasts

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GOSS

Business Wire

10 months ago

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Gossamer Bio, Inc. (NASDAQ:GOSS) Just Reported And Analysts Have Been Lifting Their Price Targets
GOSS

Simply Wall St.

10 months ago

Gossamer Bio, Inc. (NASDAQ:GOSS) Just Reported And Analysts Have Been Lifting Their Price Targets

Gossamer Bio (GOSS) Reports Q3 Loss, Tops Revenue Estimates
GOSS

Zacks

10 months ago

Gossamer Bio (GOSS) Reports Q3 Loss, Tops Revenue Estimates

GOSS

Associated Press Finance

10 months ago

Gossamer Bio: Q3 Earnings Snapshot

Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update
GOSS

Business Wire

10 months ago

Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update

NRx Pharmaceuticals added to Emerging Growth Conference 76 on October 31 and Update to Schedule
GOSS

GlobeNewswire

10 months ago

NRx Pharmaceuticals added to Emerging Growth Conference 76 on October 31 and Update to Schedule

Presenting on the Emerging Growth Conference 76 Day 2 on October 31 Register Now
GOSS

GlobeNewswire

10 months ago

Presenting on the Emerging Growth Conference 76 Day 2 on October 31 Register Now

Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now
GOSS

GlobeNewswire

10 months ago

Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now

3 US Penny Stocks With Market Caps Under $900M To Consider
GOSS

Simply Wall St.

10 months ago

3 US Penny Stocks With Market Caps Under $900M To Consider

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GOSS

Business Wire

a year ago

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Several Insiders Invested In Gossamer Bio Flagging Positive News
GOSS

Simply Wall St.

a year ago

Several Insiders Invested In Gossamer Bio Flagging Positive News

Presenting on the Emerging Growth Conference 75 Day 2 on September 26
GOSS

GlobeNewswire

a year ago

Presenting on the Emerging Growth Conference 75 Day 2 on September 26

Gossamer Bio Announces Data Presentations at the European Respiratory Society Congress 2024
GOSS

Business Wire

a year ago

Gossamer Bio Announces Data Presentations at the European Respiratory Society Congress 2024

Presenting on the Emerging Growth Conference 74 Day 2 on August 22 Register Now
GOSS

GlobeNewswire

a year ago

Presenting on the Emerging Growth Conference 74 Day 2 on August 22 Register Now

Analysts Just Made A Notable Upgrade To Their Gossamer Bio, Inc. (NASDAQ:GOSS) Forecasts
GOSS

Simply Wall St.

a year ago

Analysts Just Made A Notable Upgrade To Their Gossamer Bio, Inc. (NASDAQ:GOSS) Forecasts

With 73% institutional ownership, Gossamer Bio, Inc. (NASDAQ:GOSS) is a favorite amongst the big guns
GOSS

Simply Wall St.

a year ago

With 73% institutional ownership, Gossamer Bio, Inc. (NASDAQ:GOSS) is a favorite amongst the big guns

Gossamer Bio (GOSS) Q2 Earnings and Revenues Lag Estimates
GOSS

Zacks

a year ago

Gossamer Bio (GOSS) Q2 Earnings and Revenues Lag Estimates

GOSS

Associated Press Finance

a year ago

Gossamer Bio: Q2 Earnings Snapshot

Gossamer Bio Announces Second Quarter 2024 Financial Results and Provides Business Update
GOSS

Business Wire

a year ago

Gossamer Bio Announces Second Quarter 2024 Financial Results and Provides Business Update

Why Is Gossamer Bio, Inc. (GOSS) the Best One-Dollar Stock to Buy Now?
GOSS

Insider Monkey

a year ago

Why Is Gossamer Bio, Inc. (GOSS) the Best One-Dollar Stock to Buy Now?

GOSS

MT Newswires

a year ago

Oppenheimer Initiates Gossamer Bio at Outperform With $9 Price Target

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers
GOSS

GOBankingRates

a year ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller
GOSS

AFP

a year ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up
GOSS

AFP

a year ago

Italy beat Bosnia in final Euros warm-up

Trump loyalists proud to support 'felon' at Las Vegas rally
GOSS

AFP

a year ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia
GOSS

Business Insider

a year ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women
GOSS

Insider Monkey

a year ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase
GOSS

Reuters

a year ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

GOSS

Insider Monkey

a year ago

Best Date Night Fragrance in 2024

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GOSS

Business Wire

a year ago

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Gossamer Bio to Provide Updated Seralutinib TORREY Open-Label Extension Data at the American Thoracic Society 2024 International Conference
GOSS

Business Wire

a year ago

Gossamer Bio to Provide Updated Seralutinib TORREY Open-Label Extension Data at the American Thoracic Society 2024 International Conference

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GOSS

Business Wire

a year ago

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GOSS

Associated Press Finance

a year ago

Gossamer Bio: Q1 Earnings Snapshot

Gossamer Bio Announces First Quarter 2024 Financial Results and Provides Business Update
GOSS

Business Wire

a year ago

Gossamer Bio Announces First Quarter 2024 Financial Results and Provides Business Update

Gossamer Bio and Chiesi partner for pulmonary hypertension treatment
GOSS

Pharmaceutical Technology

a year ago

Gossamer Bio and Chiesi partner for pulmonary hypertension treatment

Gossamer Bio and Chiesi link for pulmonary hypertension treatment
GOSS

Pharmaceutical Technology

a year ago

Gossamer Bio and Chiesi link for pulmonary hypertension treatment

Gossamer Bio Collaborates With Italian Drugmaker Chiesi To Advance Lung Health Solutions Worldwide
GOSS

Benzinga

a year ago

Gossamer Bio Collaborates With Italian Drugmaker Chiesi To Advance Lung Health Solutions Worldwide

GOSS

Reuters

a year ago

UPDATE 1-Gossamer Bio and Chiesi Group to collaborate in therapy for lung condition

Gossamer sells rights to drug it hopes can rival a new Merck therapy
GOSS

BioPharma Dive

a year ago

Gossamer sells rights to drug it hopes can rival a new Merck therapy

GOSS

Reuters

a year ago

Gossamer Bio and Chiesi Group to collaborate for blood pressure treatment

Gossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in PAH, PH-ILD & Other Indications
GOSS

Business Wire

a year ago

Gossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in PAH, PH-ILD & Other Indications

Gossamer Bio Announces Publication of TORREY Phase 2 Results in the Lancet Respiratory Medicine
GOSS

Business Wire

a year ago

Gossamer Bio Announces Publication of TORREY Phase 2 Results in the Lancet Respiratory Medicine

Gossamer Bio Decline Means Insider Profits Down To US$17k
GOSS

Simply Wall St.

a year ago

Gossamer Bio Decline Means Insider Profits Down To US$17k

13 Best Biotech Stocks To Buy Under $20
GOSS

Insider Monkey

a year ago

13 Best Biotech Stocks To Buy Under $20

Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors
GOSS

Business Wire

a year ago

Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors

Should You Buy Gossamer Bio (GOSS) After Golden Cross?
GOSS

Zacks

2 years ago

Should You Buy Gossamer Bio (GOSS) After Golden Cross?

GOSS

Associated Press Finance

2 years ago

Gossamer Bio: Q4 Earnings Snapshot

Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
GOSS

Business Wire

2 years ago

Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

12 Best Medical Stocks to Buy Under $10
GOSS

Insider Monkey

2 years ago

12 Best Medical Stocks to Buy Under $10

SurModics (SRDX) Reports Break-Even Earnings for Q1
GOSS

Zacks

2 years ago

SurModics (SRDX) Reports Break-Even Earnings for Q1

WestRock (WRK) Q1 Earnings and Revenues Miss Estimates
GOSS

Zacks

2 years ago

WestRock (WRK) Q1 Earnings and Revenues Miss Estimates

7 Micro-Cap Stocks That Could Majorly Surprise Investors
GOSS

InvestorPlace

2 years ago

7 Micro-Cap Stocks That Could Majorly Surprise Investors

loanDepot’s Dan Hanson inducted to California Homebuilding Foundation’s Hall of Fame
GOSS

Business Wire

2 years ago

loanDepot’s Dan Hanson inducted to California Homebuilding Foundation’s Hall of Fame

ibex Launches Wave iX: The Next Evolution in AI-Powered Digital-First Customer Experience
GOSS

GlobeNewswire

2 years ago

ibex Launches Wave iX: The Next Evolution in AI-Powered Digital-First Customer Experience

Greenfire Resources Announces Operational Update, Including Strong Initial Refill Well Results and New WTI Hedging Program
GOSS

Newsfile

2 years ago

Greenfire Resources Announces Operational Update, Including Strong Initial Refill Well Results and New WTI Hedging Program

LINKBANCORP, Inc. Announces Fourth Quarter 2023 and Full Year 2023 Financial Results
GOSS

PR Newswire

2 years ago

LINKBANCORP, Inc. Announces Fourth Quarter 2023 and Full Year 2023 Financial Results

Owning 37% shares,institutional owners seem interested in NexPoint Real Estate Finance, Inc. (NYSE:NREF),
GOSS

Simply Wall St.

2 years ago

Owning 37% shares,institutional owners seem interested in NexPoint Real Estate Finance, Inc. (NYSE:NREF),

Heron Therapeutics, Inc. (NASDAQ:HRTX) is largely controlled by institutional shareholders who own 52% of the company
GOSS

Simply Wall St.

2 years ago

Heron Therapeutics, Inc. (NASDAQ:HRTX) is largely controlled by institutional shareholders who own 52% of the company

Share on Social Networks: